MATINAS BIOPHARMA HOLDINGS, INC. Increase (Decrease) in Accrued Liabilities
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Increase (Decrease) in Accrued Liabilities of -$230.74 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2018-11-09
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2018-09-30 was -$181.26K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2018-06-30 was $477.37K, a 121.76% increase year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2018-03-31 was -$526.85K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2017-12-31 was $160.48K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accrued liabilities for fiscal 2017 was $159.36K, a 27.40% decline from fiscal 2016.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accrued liabilities for fiscal 2016 was $219.52K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accrued liabilities for fiscal 2015 was -$285.05K, a 171.23% decline from fiscal 2014.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accrued liabilities for fiscal 2014 was $400.20K, a 13.42% decline from fiscal 2013.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2018-09-30 | -$181.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $296.11K derived: sum of 2 quarters · filed 2018-11-09 | -$230.74K 10-Q · filed 2018-11-09 | -$70.26K derived: sum of 4 quarters · filed 2018-11-09 | |
| 2018-06-30 | $477.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$49.48K 10-Q · filed 2018-08-09 | $111.00K derived: sum of 3 quarters · filed 2018-08-09 | $88.18K derived: sum of 4 quarters · filed 2018-11-09 | |
| 2018-03-31 | -$526.85K 10-Q · filed 2018-05-09 | -$366.37K derived: sum of 2 quarters · filed 2018-05-09 | -$389.19K derived: sum of 3 quarters · filed 2018-11-09 | -$173.92K derived: sum of 4 quarters · filed 2018-11-09 | |
| 2017-12-31 | $160.48K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $137.66K derived: sum of 2 quarters · filed 2018-11-09 | $352.93K derived: sum of 3 quarters · filed 2018-11-09 | $159.36K 10-K · filed 2018-03-16 | |
| 2017-09-30 | -$22.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $192.45K derived: sum of 2 quarters · filed 2018-11-09 | -$1.12K 10-Q · filed 2018-11-09 | -$112.73K derived: sum of 4 quarters · filed 2018-11-09 | |
| 2017-06-30 | $215.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $21.70K 10-Q · filed 2018-08-09 | -$89.91K derived: sum of 3 quarters · filed 2018-08-09 | $78.16K derived: sum of 4 quarters · filed 2018-08-09 | |
| 2017-03-31 | -$193.57K 10-Q · filed 2018-05-09 | -$305.18K derived: sum of 2 quarters · filed 2018-05-09 | -$137.10K derived: sum of 3 quarters · filed 2018-05-09 | -$53.08K derived: sum of 4 quarters · filed 2018-05-09 | |
| 2016-12-31 | -$111.61K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $56.47K derived: sum of 2 quarters · filed 2018-03-16 | $140.49K derived: sum of 3 quarters · filed 2018-03-16 | $219.52K 10-K · filed 2018-03-16 | |
| 2016-09-30 | $168.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $252.09K derived: sum of 2 quarters · filed 2017-11-14 | $331.13K 10-Q · filed 2017-11-14 | $338.13K derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-06-30 | $84.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $163.05K 10-Q · filed 2017-08-08 | $170.05K derived: sum of 3 quarters · filed 2018-03-16 | $361.93K derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-03-31 | $79.03K 10-Q · filed 2017-05-15 | $86.03K derived: sum of 2 quarters · filed 2018-03-16 | $277.91K derived: sum of 3 quarters · filed 2018-03-16 | -$172.67K derived: sum of 4 quarters · filed 2018-03-16 | |
| 2015-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $198.88K derived: sum of 2 quarters · filed 2018-03-16 | -$251.70K derived: sum of 3 quarters · filed 2018-03-16 | -$285.05K 10-K · filed 2018-03-16 | |
| 2015-09-30 | $191.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$258.70K derived: sum of 2 quarters · filed 2016-11-14 | -$292.05K 10-Q · filed 2016-11-14 | -$254.85K 10-Q · filed 2015-11-10 | -$261.94K derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | -$450.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$483.93K 10-Q · filed 2016-08-15 | -$453.81K derived: sum of 3 quarters · filed 2016-08-15 | ||
| 2015-03-31 | -$33.35K 10-Q · filed 2016-05-13 | -$3.24K derived: sum of 2 quarters · filed 2016-05-13 | |||
| 2014-12-31 | $30.11K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $400.20K 10-K · filed 2016-03-30 | |||
| 2014-09-30 | $370.09K 10-Q · filed 2015-11-10 | ||||
| 2013-12-31 | $462.25K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |